Publications by authors named "Kevin M Kalinsky"

Claim this Profile
Q
Q-TWiST Analysis to Assess Benefit-Risk of Sacituzumab Govitecan in Previously Treated Patients With Metastatic Triple-Negative Breast Cancer.
Aditya Bardia, Hope S Rugo, Mina S Sedrak, Sibylle Loibl, Sara M Tolaney, Kevin M Kalinsky

JCO Oncol Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer.
Lajos Pusztai, Jess R Hoag, Kathy S Albain, William E Barlow, Salomon M Stemmer, Kevin M Kalinsky

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a Smartphone Application to Promote Adherence to Oral Medications in Patients With Breast Cancer.
Claire Sathe, Rohit Raghunathan, Sophie Ulene, Fiona McAuley, Kishan A Bhatt, Kevin M Kalinsky

JCO Oncol Pract· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.
Katia Khoury, Jane L Meisel, Christina Yau, Hope S Rugo, Rita Nanda, Kevin M Kalinsky

Nat Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-centered dosing: oncologists' perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC).
Anne L Loeser, Lucy Gao, Aditya Bardia, Mark E Burkard, Kevin M Kalinsky

Breast Cancer Res Treat· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer.
Rami S Vanguri, Kathleen M Fenn, Matthew R Kearney, Qi Wang, Hua Guo, Kevin M Kalinsky

Clin Breast Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
Judy C Boughey, Michael D Alvarado, Rachael B Lancaster, W Fraser Symmans, Rita Mukhtar, Kevin M Kalinsky

NPJ Breast Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
Judy C Boughey, Michael D Alvarado, Rachael B Lancaster, W Fraser Symmans, Rita Mukhtar, Kevin M Kalinsky

NPJ Breast Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis